✦ LIBER ✦

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

✍ Scribed by Van Tendeloo, V. F.; Van de Velde, A.; Van Driessche, A.; Cools, N.; Anguille, S.; Ladell, K.; Gostick, E.; Vermeulen, K.; Pieters, K.; Nijs, G.; Stein, B.; Smits, E. L.; Schroyens, W. A.; Gadisseur, A. P.; Vrelust, I.; Jorens, P. G.; Goossens, H.; de Vries, I. J.; Price, D. A.; Oji, Y.; Oka, Y.; Sugiyama, H.; Berneman, Z. N.

Book ID: 117991509
Publisher: National Academy of Sciences
Year: 2010
Tongue: English
Weight: 350 KB
Volume: 107
Category: Article
ISSN: 0027-8424
DOI: 10.1073/pnas.1008051107

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of complete and molecular remi

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination

✍ Van Tendeloo, V. F.; Van de Velde, A.; Van Driessche, A.; Cools, N.; Anguille, S 📂 Article 📅 2010 🏛 National Academy of Sciences 🌐 English ⚖ 350 KB

Active immunization using tumor antigen-loaded dendritic cells holds promise for the adjuvant treatment of cancer to eradicate or control residual disease, but so far, most dendritic cell trials have been performed in end-stage cancer patients with high tumor loads. Here, in a phase I/II trial, we i